Amy L. Cole

3.1k total citations
44 papers, 2.0k citations indexed

About

Amy L. Cole is a scholar working on Microbiology, Virology and Infectious Diseases. According to data from OpenAlex, Amy L. Cole has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Microbiology, 15 papers in Virology and 12 papers in Infectious Diseases. Recurrent topics in Amy L. Cole's work include Antimicrobial Peptides and Activities (16 papers), HIV Research and Treatment (15 papers) and Reproductive tract infections research (13 papers). Amy L. Cole is often cited by papers focused on Antimicrobial Peptides and Activities (16 papers), HIV Research and Treatment (15 papers) and Reproductive tract infections research (13 papers). Amy L. Cole collaborates with scholars based in United States, Sweden and Kenya. Amy L. Cole's co-authors include Alexander M. Cole, Judith A. Berliner, Michael W. Yeh, Jan Pohl, Alan J. Waring, Nitya Venkataraman, Ganesamoorthy Subbanagounder, Pavel Svoboda, Robert I. Lehrer and Nima M. Gharavi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Amy L. Cole

43 papers receiving 2.0k citations

Peers

Countries citing papers authored by Amy L. Cole

Since Specialization

Citations

This map shows the geographic impact of Amy L. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Cole more than expected).

Fields of papers citing papers by Amy L. Cole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Cole. The network helps show where Amy L. Cole may publish in the future.

Co-authorship network of co-authors of Amy L. Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Cole. A scholar is included among the top collaborators of Amy L. Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Cole. Amy L. Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avirulins, a Novel Class of HIV-1 Reverse Transcriptase Inhibitors Effective in the Female Reproductive Tract Mucosa 2019 ·Viruses ·(unknown), Jesse Hall, (unknown), (unknown), Amy L. Cole, Alexander M. Cole, (unknown), (unknown)	6
2	HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins 2017 ·Viruses ·Alexander M. Cole, Amy L. Cole, (unknown), (unknown)	6
3	Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents 2016 ·Bioorganic & Medicinal Chemistry ·Amy L. Cole, (unknown), (unknown), Otto Phanstiel	79
4	Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers 2015 ·PLoS ONE ·Kenzie Birse, Amy L. Cole, Taha Hirbod, Lyle R. McKinnon, T. Blake Ball, Garrett Westmacott, Joshua Kimani, Frank Plummer, Alexander M. Cole, Adam Burgener, Kristina Broliden	5
5	HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria 2015 ·Protein and Peptide Letters ·Colleen R. Eade, (unknown), Sixue Chen, Amy L. Cole, Alexander M. Cole	4
6	The HIV‐1 gp41 ectodomain is cleaved by matriptase to produce a chemotactic peptide that acts through FPR2 2014 ·Immunology ·(unknown), Amy L. Cole, Colleen R. Eade, Li‐Mei Chen, Karl X. Chai, Alexander M. Cole	13
7	A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion 2013 ·PLoS ONE ·(unknown), Amy L. Cole, Piotr Ruchała, Alan J. Waring, Lisa C. Rohan, Preston A. Marx, Patrick M. Tarwater, Phalguni Gupta, Alexander M. Cole	12
8	Identification and Characterization of Bacterial Vaginosis-Associated Pathogens Using a Comprehensive Cervical-Vaginal Epithelial Coculture Assay 2012 ·PLoS ONE ·Colleen R. Eade, (unknown), (unknown), Kathryn Anastos, Bruce K. Patterson, Phalguni Gupta, Amy L. Cole, Alexander M. Cole, (unknown), (unknown)	65
9	The Anti‐HIV Microbicide Candidate RC‐101 Inhibits Pathogenic Vaginal Bacteria Without Harming Endogenous Flora or Mucosa 2012 ·American Journal of Reproductive Immunology ·Colleen R. Eade, Amy L. Cole, (unknown), Lisa C. Rohan, Michael A. Parniak, Preston A. Marx, Patrick M. Tarwater, Phalguni Gupta, (unknown), (unknown)	14
10	HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma 2011 ·PLoS ONE ·(unknown), Amy L. Cole, Pavel Svoboda, Olga Stuchlik, Li‐Mei Chen, Karl X. Chai, Bhushan K. Gangrade, Ole E. Sørensen, Jan Pohl, Alexander M. Cole	23
11	Characterization of the Retrocyclin Analogue RC-101 as a Preventative of Staphylococcus aureus Nasal Colonization 2011 ·Antimicrobial Agents and Chemotherapy ·Ryan P. Lamers, Colleen R. Eade, Alan J. Waring, Amy L. Cole, Alexander M. Cole, (unknown), (unknown)	15
12	The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques 2010 ·PLoS ONE ·Alexander M. Cole, Dorothy L. Patton, Lisa C. Rohan, Amy L. Cole, (unknown), (unknown), Deena Ratner, Alexandra B. Sassi, Carol Lackman-Smith, Patrick M. Tarwater, Bharat Ramratnam, Piotr Ruchała, Robert I. Lehrer, Alan J. Waring, Phalguni Gupta	133
13	Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin 2010 ·PLoS ONE ·Ewa D. Micewicz, Amy L. Cole, Chun‐Ling Jung, (unknown), Martin L. Phillips, (unknown), Shantanu Sharma, Alan J. Waring, Alexander M. Cole, Piotr Ruchała	68
14	Reawakening Retrocyclins: Ancestral Human Defensins Active Against HIV-1 2009 ·PLoS Biology ·Nitya Venkataraman, Amy L. Cole, Piotr Ruchała, Alan J. Waring, Robert I. Lehrer, Olga Stuchlik, Jan Pohl, Alexander M. Cole	72
15	Field production and functional evaluation of chloroplast‐derived interferon‐α2b 2007 ·Plant Biotechnology Journal ·Philip A. Arlen, (unknown), (unknown), Amy L. Cole, Alexander M. Cole, K. K. Oishi, Henry Daniell	121
16	The role of human innate immune factors in nasal colonization by Staphylococcus aureus 2007 ·Microbes and Infection ·Alex van Belkum, Marieke Emonts, Heiman Wertheim, Christa E. van der Gaast‐de Jongh, Jan Nouwen, (unknown), Alexander M. Cole, Amy L. Cole, Peter W. M. Hermans, Hélène Boelens, Nicole Lemmens‐den Toom, Susan V. Snijders, Henri A. Verbrugh, Willem van Leeuwen	56
17	REVIEW ARTICLE: Antimicrobial Polypeptides are Key Anti‐HIV‐1 Effector Molecules of Cervicovaginal Host Defense 2007 ·American Journal of Reproductive Immunology ·Alexander M. Cole, Amy L. Cole	85
18	The retrocyclin analogue RC‐101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct 2007 ·Immunology ·Amy L. Cole, Anna Herasimtschuk, Phalguni Gupta, Alan J. Waring, Robert I. Lehrer, Alexander M. Cole	33
19	Cationic Polypeptides Are Required for Anti-HIV-1 Activity of Human Vaginal Fluid 2005 ·The Journal of Immunology ·Nitya Venkataraman, Amy L. Cole, Pavel Svoboda, Jan Pohl, Alexander M. Cole	128
20	Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8 2003 ·Journal of Biological Chemistry ·(unknown), (unknown), Nima M. Gharavi, Shirley Wang, Grace Wang, Michael W. Yeh, Amy L. Cole, Judith A. Berliner	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact